Zein/polycaprolactone electrospun matrices for localised controlled delivery of tetracycline

Research output: Contribution to journalArticle

  • 11 Citations

Abstract

We report the controlled release of the antibiotic tetracycline (Tet) from triple-layered (3L) electrospun matrices consisting of zein or a zein/PCL blend, where the drug was loaded into the central layer with the two outer layers acting as diffusion barriers. These fibrous matrices successfully encapsulated Tet and efficiently inhibited the growth of a clinical isolate, the methicillin-resistant Staphylococcus aureus strain MRSA252, as demonstrated in a modified Kirby–Bauer disc assay over 5 days. Whilst untreated zein fibres are unstable in an aqueous environment, rapidly shrinking due to plasticisation and film formation, blending zein with PCL stabilised the electrospun matrices and prevented them from shrinking. These 3L formulations display sustained antibiotic release and provide a proof of concept for zein-based polymeric matrices as wound dressings to treat or prevent bacterial infection. This is the first demonstration of the controlled release of a clinically used antibiotic from electrospun zein-based matrices.
LanguageEnglish
Pages542-550
Number of pages9
JournalDrug Delivery and Translational Research
Volume3
Issue number6
Early online date2 Oct 2013
DOIs
StatusPublished - Dec 2013

Fingerprint

Zein
Tetracycline
Anti-Bacterial Agents
Bandages
Methicillin-Resistant Staphylococcus aureus
Bacterial Infections
polycaprolactone
Wounds and Injuries
Growth
Pharmaceutical Preparations

Cite this

@article{932e8b42c1ab48809d268d68065338ee,
title = "Zein/polycaprolactone electrospun matrices for localised controlled delivery of tetracycline",
abstract = "We report the controlled release of the antibiotic tetracycline (Tet) from triple-layered (3L) electrospun matrices consisting of zein or a zein/PCL blend, where the drug was loaded into the central layer with the two outer layers acting as diffusion barriers. These fibrous matrices successfully encapsulated Tet and efficiently inhibited the growth of a clinical isolate, the methicillin-resistant Staphylococcus aureus strain MRSA252, as demonstrated in a modified Kirby–Bauer disc assay over 5 days. Whilst untreated zein fibres are unstable in an aqueous environment, rapidly shrinking due to plasticisation and film formation, blending zein with PCL stabilised the electrospun matrices and prevented them from shrinking. These 3L formulations display sustained antibiotic release and provide a proof of concept for zein-based polymeric matrices as wound dressings to treat or prevent bacterial infection. This is the first demonstration of the controlled release of a clinically used antibiotic from electrospun zein-based matrices.",
author = "Nour Alhusein and Blagbrough, {Ian S.} and {De Bank}, {Paul A.}",
year = "2013",
month = "12",
doi = "10.1007/s13346-013-0179-2",
language = "English",
volume = "3",
pages = "542--550",
journal = "Drug Delivery and Translational Research",
issn = "2190-393X",
publisher = "Springer Publishing Company",
number = "6",

}

TY - JOUR

T1 - Zein/polycaprolactone electrospun matrices for localised controlled delivery of tetracycline

AU - Alhusein,Nour

AU - Blagbrough,Ian S.

AU - De Bank,Paul A.

PY - 2013/12

Y1 - 2013/12

N2 - We report the controlled release of the antibiotic tetracycline (Tet) from triple-layered (3L) electrospun matrices consisting of zein or a zein/PCL blend, where the drug was loaded into the central layer with the two outer layers acting as diffusion barriers. These fibrous matrices successfully encapsulated Tet and efficiently inhibited the growth of a clinical isolate, the methicillin-resistant Staphylococcus aureus strain MRSA252, as demonstrated in a modified Kirby–Bauer disc assay over 5 days. Whilst untreated zein fibres are unstable in an aqueous environment, rapidly shrinking due to plasticisation and film formation, blending zein with PCL stabilised the electrospun matrices and prevented them from shrinking. These 3L formulations display sustained antibiotic release and provide a proof of concept for zein-based polymeric matrices as wound dressings to treat or prevent bacterial infection. This is the first demonstration of the controlled release of a clinically used antibiotic from electrospun zein-based matrices.

AB - We report the controlled release of the antibiotic tetracycline (Tet) from triple-layered (3L) electrospun matrices consisting of zein or a zein/PCL blend, where the drug was loaded into the central layer with the two outer layers acting as diffusion barriers. These fibrous matrices successfully encapsulated Tet and efficiently inhibited the growth of a clinical isolate, the methicillin-resistant Staphylococcus aureus strain MRSA252, as demonstrated in a modified Kirby–Bauer disc assay over 5 days. Whilst untreated zein fibres are unstable in an aqueous environment, rapidly shrinking due to plasticisation and film formation, blending zein with PCL stabilised the electrospun matrices and prevented them from shrinking. These 3L formulations display sustained antibiotic release and provide a proof of concept for zein-based polymeric matrices as wound dressings to treat or prevent bacterial infection. This is the first demonstration of the controlled release of a clinically used antibiotic from electrospun zein-based matrices.

UR - http://www.scopus.com/inward/record.url?scp=84887157072&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1007/s13346-013-0179-2

U2 - 10.1007/s13346-013-0179-2

DO - 10.1007/s13346-013-0179-2

M3 - Article

VL - 3

SP - 542

EP - 550

JO - Drug Delivery and Translational Research

T2 - Drug Delivery and Translational Research

JF - Drug Delivery and Translational Research

SN - 2190-393X

IS - 6

ER -